DOW INC. DL-,01/ US2605571031 /
2024-04-19 10:43:35 AM | Chg. -0.070 | Volume | Bid12:28:39 PM | Ask12:28:39 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
52.760EUR | -0.13% | - Turnover: - |
52.770Bid Size: 750 | 52.920Ask Size: 750 | 37.27 bill.EUR | - | - |
GlobeNewswire
02-13
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
GlobeNewswire
01-22
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
GlobeNewswire
2023-11-16
Dow Jones Appoints Global Agency Partners to Accelerate Marketing Transformation and Subscription Gr...
GlobeNewswire
2023-10-11
Dow Jones Risk & Compliance Completes ISAE 3000 Assurance for Ninth Consecutive Year
GlobeNewswire
2023-09-06
60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conferenc...
GlobeNewswire
2021-11-17
Gildan Included on the 2021 Dow Jones Sustainability Index for the Ninth Consecutive Year